Loading...
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
High-quality chondroitin sulfate is as effective as celecoxib in treating knee osteoarthritis, according to an international trial in the Annals of the Rheumatic Diseases.
Roughly 600 adults older than 50 with primary knee osteoarthritis were randomized to receive pharmaceutical-grade chondroitin sulfate (800 mg) plus placebo, celecoxib (200 mg) plus placebo, or double placebo daily for 6 months.
At the end of treatment, the chondroitin and celecoxib groups had significantly greater reductions in pain relative to the placebo group, with no difference between the two active treatments. Similarly, at 3 and 6 months, chondroitin and celecoxib conferred significant improvements in function relative to placebo, again with no difference between the two active groups.
The authors, noting the risks associated with long-term use of NSAIDs and acetaminophen, say chondroitin sulfate "should be considered a first-line treatment in the medical management of knee OA."
Comment
LINK(S):
Annals of the Rheumatic Diseases article (Free)
Background: NEJM Journal Watch General Medicine coverage of recent trial showing no benefit of glucosamine/chondroitin over placebo (Your NEJM Journal Watch subscription required)